Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
@Smont #9 Prohibititely expensive for most
The peptide is currently sold for research purposes only and lacks FDA approval for human therapeutic use
The typical patient profile for whom MIC B12 represents good value: confirmed or suspected B12 deficiency, seeking energy improvement and modest weight-loss support, not ready for or not qualifying for GLP-1 therapy, willing to self-inject weekly
This condition not only disrupts sleep but also increases risks for high blood pressure and heart disease
Oral B12 supplements require daily intake and have much lower bioavailability only about 1 to 2% is absorbed without intrinsic factor.
Autonomic : postural hypotension, incontinence (which often seems to be urgency incontinence)
US$ 27.86
US$ 25.02
US$ 21.93
US$ 29.32
